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Background: Aquaporin channels ensure appropriate membrane permeability to water in all cells.
Results: Following a hypotonic stimulus, subcellular localization of aquaporin 1 occurs via amechanismdependent on transient
receptor potential channels, extracellular calcium influx, calmodulin, and the phosphorylation of two threonines (157 and 239)
of aquaporin 1.
Conclusion: Rapid translocation of aquaporin 1 regulates membrane water permeability.
Significance: This mechanism may serve as a prototype for the rapid regulation of aquaporin function.
The control of cellular water flow is mediated by the aqua-
porin (AQP) family of membrane proteins. The structural
features of the family and the mechanism of selective water
passage through the AQP pore are established, but there
remains a gap in our knowledge of how water transport is
regulated. Two broad possibilities exist. One is controlling
the passage of water through the AQP pore, but this only has
been observed as a phenomenon in some plant and microbial
AQPs. An alternative is controlling the number of AQPs in
the cell membrane. Here, we describe a novel pathway in
mammalian cells whereby a hypotonic stimulus directly
induces intracellular calcium elevations through transient
receptor potential channels, which trigger AQP1 transloca-
tion. This translocation, which has a direct role in cell volume
regulation, occurs within 30 s and is dependent on calmodu-
lin activation and phosphorylation of AQP1 at two threonine
residues by protein kinase C. This direct mechanism provides
a rationale for the changes in water transport that are
required in response to constantly changing local cellular
water availability. Moreover, because calcium is a pluripotent
and ubiquitous second messenger in biological systems, the
discovery of its role in the regulation of AQP translocation
has ramifications for diverse physiological and pathophysio-
logical processes, as well as providing an explanation for the
rapid regulation of water flow that is necessary for cell
homeostasis.
The flow of water across cell membranes is fundamental to
the physiology of all organisms. It is now clear that osmosis is
not sufficient for this purpose; rather aquaporin (AQP)4 chan-
nels are required to ensure appropriatemembrane permeability
to watermolecules (1, 2). Over the past two decades, themolec-
ular basis of selective water passage through the AQP pore (3,
4), as well as the structural biology of the family (5), have been
established. However, there is a gap in our current understand-
ing of howAQPs regulate the flow of water in and out of cells to
meet the constant and rapid changes in local water availability
that challenge them.
Membrane permeability to water is a function of the proper-
ties of theAQPpore aswell as the abundance ofAQPmolecules
in the cell membrane. TheAQP pore is acknowledgedwidely to
be constitutively open and highly specific. Some AQPs are per-
meable only to water, whereas others (e.g. the aquaglycero-
porins) are permeable to both water and small non-ionic mol-
ecules such as glycerol, urea, and ammonia (3, 4, 6). Regulation
via gatingmechanisms, which allow open and closed states, has
been reported for some plant and microbial AQPs (7). How-
ever, this is not a widely accepted regulatory mechanism for
mammalian AQPs (8).
Regulation of AQP abundance, the number of pores per unit
plasma membrane, is possible via several mechanisms. Direct
regulation by AQP gene expression and/or AQP protein degra-
dation can be achieved over a time scale from hours to days (9,
10). Indirect, receptor-mediatedmechanisms (11, 12) also have
been described that account for more rapid regulation of AQP
abundance on a time scale of minutes (13, 14). The best studied
example of this is the regulation of AQP2 translocation in
human kidney cells, which is dependent on vasopressin-medi-
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ated activation of protein kinase A by the G protein-coupled
receptor, vasopressin V2 receptor (15). Of the 13 known AQPs
in the human body, AQP1 (16), AQP3 (17), and AQP5 (18) also
have been shown to undergo translocation to the plasmamem-
brane in response to hormonal activation of specific G protein-
coupled receptors.
Neither gene expression nor indirect, receptor-mediated
translocation can explain the direct regulation of AQPs that
may be necessary to respond to the rapidly changing extracel-
lular environment on a time scale of seconds.We recently dem-
onstrated that increased translocation of AQP1 is triggered on
this rapid timescale by hypotonic stimulus in a specific protein
kinaseC (PKC)- andmicrotubule-dependentmanner (19). Fur-
thermore, returning the extracellular environment to its origi-
nal tonicity reversed this dynamic subcellular localization. In
contrast, a hypotonic stimulus had little effect on AQP2 local-
ization in the absence of the vasopressin V2 receptor required
for AQP2 translocation (19).
The change in cell volume that results from the transport of
water across biological membranes is thought to be dependent
on PKC and calcium, as well as the presence of transient recep-
tor potential (TRP) channels and AQPs (20–22). The data pre-
sented here provide evidence of a mechanistic link between
these elements. In this study, we combined laser scanning con-
focal microscopy of chimeras of AQP1 with green fluorescent
protein (AQP1-GFP), calcium imaging, and mutagenesis to
determine that AQP1 translocation underpins the regulation of
cellular water flow, as measured by changes in cell volume. Our
data show that manipulating rapid AQP1 translocation, which
can be observed in primary astrocytes aswell asmodel cell lines,
modulates changes in cell volume and that this rapid subcellu-
lar localization of AQP1 requires extracellular calcium influx,
TRP channels, calmodulin, and specific phosphorylation at two
known PKC sites, Thr-157 and Thr-239. We therefore suggest
that the regulation of AQPs provides the rapid homeostatic
control required by cells in a constantly changing osmotic
environment.
EXPERIMENTAL PROCEDURES
Materials—Cell-permeable inhibitors were purchased as fol-
lows: phorbol 12-myristate 13-acetate (PMA; ED50  1 nM
(23)), 1-oleoyl-2-acetyl-sn-glycerol (ED50 inM range butmore
specific than PMA (24, 25)), caffeine (Kd 10 nM (26)), andW7
calmodulin antagonist (N-(6-aminohexyl)–5-chloronaphtha-
lene-1-sulfonamide; Kd  1 M (27, 28)) from Sigma; TRPC1
antagonist SKF96365 (10 mM concentrations are utilized typi-
cally to assay TRPC function (29)) from Ascent Scientific, Ltd.
(Bristol, UK); Myr-PKC 19–27 and hypericin (Kd  100 nM
(30)) from Fisher Scientific (Loughborough, UK); Myr-PKA
14–22 from Merck Chemicals (Nottingham, UK); and CPA
(cyclopiazonic acid; inhibits sarco/endoplasmic reticulum
Ca2-ATPasewith nanomolar affinity (31)) fromTocris Biosci-
ence (Bristol, UK). FluorodishTM dishes were from WPI, Ltd.
(Stevenage, UK). Polyclonal rabbit anti-AQP1 was from Alam-
one (Jerusalem, Israel), secondary goat anti-rabbit IgG-FITC
was from Santa Cruz Biotechnology (Santa Cruz, CA), and
monoclonal anti-glial fibrillary acidic protein antibody was
fromMillipore. Gateway vectors and enzymes were from Invit-
rogen. Unless otherwise specified, all other chemicals were
from Sigma or Fisher. Cell culture reagents were from Invitro-
gen or Sigma. In each experiment, all inhibitors and activators
were analyzed using wild-type AQP1-GFP as a control.
Expression Constructs and Mutagenesis—AQPs were fused
with carboxyl-terminal GFP using the Invitrogen GatewayTM
cloning system according to the manufacturer’s instructions.
Sequence-verified AQP cDNAs were a kind gift of Dr. Kristina
Hedfalk (Göteborg University). For directional cloning of
blunt-ended PCR products into an entry vector using the Gate-
wayTM system, four bases (GGGG) were added to the 5-end of
the forward primer followed by the 25-bp attB1 attachment
sequence (underlined). This was followed by five bases (bold-
face type) to introduce a Kozak sequence upstream and to keep
the sequence in frame with the AQP coding sequence. Finally,
18–25 bpof theAQP sequencewere added to create the amino-
terminal forward primers, 5-GGGG ACA AGT TTG TAC
AAA AAA GCA GGC TCC ACC ATG-AQP(18–25 bp)-3.
For the reverse primer, four bases (GGGG) were added to the
5-end followed by the 25-bp attB2 attachment sequence
(underlined), and then one base (boldface type) was added to
keep the sequence in frame with the AQP coding sequence.
Finally, 18–25 bp of the AQP sequence without the stop codon
were added to create the carboxyl-terminal forward primers
5-GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC–
AQP(18–25 bp)-3. DNA polymerase from Thermococcus
kodakaraensis (KOD) polymerase was used in PCR amplifica-
tion of the AQP cDNA. Samples were heated to 94 °C for 2min,
followed by 30 cycles of 94 °C for 30 s, 55 °C for 30 s, and 68 °C
for 3min, and then 68 °C for 7min. Purified PCR products were
subcloned into the pDONR221TM entry vector (Invitrogen)
using theattB1 andattB2 sites in a reactionwithGatewayTMBP
ClonaseTM enzyme mix (Invitrogen). pDONR221TM vectors
containing the required sequences were recombined with the
pcDNA-DEST47 GatewayTM vector using the attL and attR
reaction with GatewayTM LR ClonaseTM enzyme mix (Invitro-
gen). This created expression vectors with the cycle 3mutant of
the GFP gene at the carboxyl terminus of the AQP gene of
interest, which were expressed subsequently as fusion proteins.
All mutant constructs were amplified using the well estab-
lished, modified QuikChange procedure (Stratagene), as
described previously (32). All plasmids were handled and puri-
fied using standard molecular biological procedures.
Cell Culture and Transfection—HEK 293 cells were cultured
routinely in DMEM supplemented with 10% (v/v) fetal bovine
serum in humidified 5% (v/v) CO2 in air at 37 °C. Cells were
seeded into 30-mm FluorodishTM dishes and transfected after
24 h at 50% confluency using the Transfast (Promega) transfec-
tion protocol with 3 g of DNA/dish. Cortices were dissected
from neonatal 2–5-day-old Wistar rats and placed in cold
HEPES-buffered saline. Following mechanical digestion in
modified glial medium (DMEM/F12 culture medium with 10%
fetal bovine serum, 1% glutamine, and 10 g/ml gentamicin),
the tissue was digested chemically in 1 trypsin and DNase for
25 min at 37 °C. The tissue was then washed twice with glial
medium and dissociated into a cell suspension by trituration
three times sequentially through a 5-ml pipette followed by a
fire-polished Pasteur pipette. Suspended cells were diluted in
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10 ml of glial medium, and passed through a 40 M strainer.
Following centrifugation (500  g for 5 min), the supernatant
was removed, and the pellet was suspended in 10 ml of glial
medium. Cells were seeded at 2 106 cells/T75 cm2 flask in 15
ml of glial medium and incubated at 37 °C in 5% CO2, changing
the medium every 2 days until confluency was achieved (6–7
days). Astrocytes were purified by shaking at 350 rpm for 6 h at
37 °C to separate oligodendrocytes from astrocytes; the glial
medium and oligodendrocytes were replaced with fresh
medium and shaken for 18 h and then again for a further 24 h
changing the medium every 6 h. Cells were reseeded at 3 105
cells/T75 cm2 flask. Identification of primary astrocytes was
confirmed by immunocytochemistry.
Primary Astrocyte Immunocytochemistry—Endogenous AQP1
protein was visualized in isolated rat primary astrocytes. Cells
grown on coverslips and exposed to glial medium or diluted glial
medium were fixed by perfusing (optimized to ensure tonicity
changes did not affect expression profile) with 4% (v/v) parafor-
maldehyde in phosphate-buffered saline for 15 min at room tem-
perature, washed twice with phosphate-buffered saline, and per-
meabilizedusingablocking solutioncontaining0.25%(v/v)Triton
X-100, 1% (v/v) goat serumand1% (w/v) bovine serumalbumin in
phosphate-buffered saline. Successive incubations with primary
and secondary antibodies were carried out for 16 h at 4 °C and 1 h
at room temperature, respectively. Primary antibodies (1:500)
were detected by species-specific FITC-conjugated secondary
antibodies (1:1,000). Cells were washed in phosphate-buffered
saline, and coverslips were mounted with Vectorshield (Vector
Laboratories). The cellswere visualized, and confocal imageswere
acquired using confocal laser scanning microscopy as described
below. Because perfused, fixed primary cells were used, the same
live cell could not be compared under differing conditions; rather,
cells from the same subcultured population were compared on
different cover slips.
Confocal Microscopy—AQP-GFP fusion proteins were visu-
alized in live cells enclosed in a full environmental chamber by
confocal laser scanning microscopy. Confocal images were
acquired with a Leica SP5 laser scanning microscope and a
Zeiss Axiovert 200 m inverted microscope with a 63 (1.4
numerical aperture) oil immersion objective for immunocyto-
chemical analysis or a Zeiss Axiovert 200muprightmicroscope
with a 20 (1.0 numerical aperture) water dipping objective for
live cell analysis. The nucleus and the plasma membrane were
stained with DAPI and 5 g/ml FM4-64 (Molecular Probes),
respectively. Images were acquired using an argon laser (exci-
tation, 488 nm; emission, band pass, 505–530 nm) for GFP, UV
excitation and a band pass 385–470 nm emission filter for
DAPI, and a He-Ne laser (excitation, 543 nm; emission filter,
long pass, 650 nm) for FM4-64. 48 h post-transfection, cells in
FluorodishesTM were incubated with or without 50 M Myr-
PKC 19–27, 50 M Myr-PKA 14–22, 50 M hypericin, 10 M
1-oleoyl-2-acetyl-sn-glycerol, 5 M PMA, 10 mM caffeine, 10
M CPA (30 min), 10 mM TRPC1 antagonist SKF96365 or 100
MW7 for 1 h at 37 °C and 5% CO2. For inhibitor and activator
experiments, the concentrations used were derived from the
literature and were a minimum of 10  Kd (where known) to
ensure 90% theoretical fractional occupancy of the target pro-
tein. Where no effect was seen, the dose was increased: for
example, 1,000 Kd achieves 99.9% fractional occupancy. The
volume of inhibitor (in water) added to the cells was1% (v/v)
to ensure aminimumeffect on osmolality. Cells were visualized
in control medium (DMEM) that has an inorganic salt concen-
tration of 120 mM, a glucose concentration of 25 mM, and an
osmolality in the range 322–374 mosM/kg H2O. Hypotonic
medium has an osmolality in the range 107–125 mosM/kg H2O
through dilution of DMEM by a factor of 3 with water. Protein
localization was measured using a line profile (pixel density)
traced on each transfected cell. Localization data are represent-
ative of three to five cells from at least three independent exper-
iments. Line expression profiles were generated and analyzed
with the program ImageJ (http://rsb.info.nih.gov/ij/) and are
indicated in yellow and displayed below each confocal image.
Determination of Subcellular Localization—A minimum of
five line profilesweremeasured anddistributed at regular inter-
vals covering the plasma membrane and the cytosol but avoid-
ing the nucleus of a minimum of three cells from at least three
independent experiments. The fluorescence intensity over this
distance was measured, and the difference between the peak
and the plateau of fluorescence was divided by the maximum
fluorescence along the line scan to calculate the percentage of
fluorescence at the membrane. This was termed the relative
membrane expression (RME) (19). Identification of the plasma
membrane was achieved by staining with FM4-64 and overlay-
ing the GFP images. Nuclei were identified though DAPI stain-
ing. The overlay of the GFP image either with the bright-field
image or the red fluorescence emitted by FM4-64 clearly indi-
cated integration of GFP-tagged AQP1 at the plasma mem-
brane as well as in the cytoplasm of HEK293 cells.
Calcium Imaging—Calcium analysis was performed as
described previously (33). Briefly, transfected cells were loaded
withFluo-4AM(Invitrogen)by incubating for40–60minat37 °C
with10Mof the indicatordyeand0.01%pluronic acid.Cellswere
placed in a recording chamber with a moveable platform (MP
MTP-01, Scientifica, Uckfield, UK) fitted to aNikon FN-1 upright
microscope.Whole-field imageswere acquired routinely every 5 s
with a 20 objective lens using a fluorescence imaging system
equippedwithaCairnoptoscanmonochromator (CairnResearch,
Faversham, UK) and an Hamamatsu ORCA-ER camera (Digital
Pixel, Brighton, UK). Typical exposure to the selectedmonochro-
mator light wavelength was 50–100ms every 1–5 s.
Estimation of Cell Volume—10-Hz confocal x-y images of the
same cell under both isotonic and hypotonic conditions were
converted to binary format using ImageJ software. The com-
parative z-position was maintained and confirmed by the
appropriation of the z-planewith the largest surface area aswell
as cross-referencing fluorescence intensity from other areas of
the selected image (34). The surface area was then calculated
using particle analysis software in ImageJ. Each estimate of cell
volume was made from at least 10 independent cells from at
least three separate experimental determinations.
RESULTS
Endogenous AQP1 Translocation Is Triggered by Hypo-
tonic Stimulus—AQP1 is found in diverse tissues (35),
including astrocytes (36). To confirm the physiological rele-
vance of hypotonicity-triggered AQP1 translocation, pri-
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mary astrocytes from rat cortex were stimulated hypotoni-
cally, perfused with formaldehyde, and examined using
confocal microscopy. GFAP (glial fibrillary acidic protein)
staining confirmed the astrocytic phenotype of the cells.
Immunostaining with an anti-AQP1 antibody suggested
increased plasma membrane localization of endogenous
AQP1: the RME significantly increased from 30  10% to
62  9%, p  0.01, following hypotonic stimulus (Fig. 1).
Interestingly, increased nuclear membrane staining was also
apparent in the primary astrocytes (Fig. 1). These results are
in agreement with our previous studies using heterologous
GFP-tagged AQP1 in HEK293 cells (19). HEK293 cells trans-
fected with heterologous, GFP-tagged AQP1 were therefore
used as a model for AQP translocation, allowing live cell
imaging of individual, treated cells (compared with the fixed
astrocytes), and analysis of AQP mutants. This model was
used for all subsequent experiments.
Cell Volume Increases with AQP1 Translocation—To estab-
lish that functional AQP1 was inserted into the plasma mem-
brane, a cell-swelling assay was performed as it is established
that aquaporins function by allowing water movements across
membranes (1, 2). Following hypotonic exposure, cell volume
was estimated using x-y surface area measurement at the
z-stack plane of maximal area (34). HEK293 cells transfected
with AQP0, which does not show increased localization at the
plasmamembrane (19) had an increase in surface area of 5 2%
(compared with cells in DMEM) after a 30-s hypotonic expo-
sure (p 0.01; Fig. 2A) compared with 28 4% for cells trans-
fected with AQP1-GFP (p  0.01; Fig. 2B). This increase was
sustained for at least 15min andwas fully reversible on removal
of the hypotonic stimulus. These functional experiments cor-
relate aquaporin translocation (as measured by the fluores-
cence distribution profiles) to functional cell swelling, strongly
suggesting that functional AQP1 is inserted into the plasma
membrane.
Phosphorylation at Both PKC Sites Is Necessary for AQP1
Translocation—To establish a causal relationship between
AQP1 translocation and the estimated increase in cell vol-
ume, we searched for mutant forms of AQP1 that would not
translocate and therefore should not affect cell volume. We
previously showed that the PKC inhibitor, Myr-PKC 19–27,
ablates rapid hypotonicity-mediated membrane transloca-
tion of AQP1 (19). In peptide mimetic studies, PKC has also
been demonstrated to phosphorylate AQP1 at T157 and
T239 (37), although no effect on translocation was mea-
sured. We therefore mutated the PKC-dependent threonine
FIGURE 1. AQP1 subcellular localization in fixed, primary rat astrocytes.
Immunocytochemistry showing expression profiles of endogenous AQP1 in
primary rat astrocytes. Cells shown in each representative image are different
fixed cells from the same subculture exposed to different osmotic conditions.
Fluorescence amplitudes (a.u., arbitrary units) along the line scans (in yellow
on the image) are displayed graphically below each image. RME is calculated
from at least five line scan analyses performed in triplicate on a minimum of
three independent experiments. Controlmediumandhypotonicmediumare
DMEMandF12at a ratioof 1:1withosmolalities of 322–374mosM/kgH2Oand
107–125mosM/kgH2O (dilutedwithwater), respectively. All images and anal-
yses shown are a single representation contributing to the mean value
quoted in the text and in Table 1.
FIGURE 2. Regulation of hypotonicity-induced increase in cell volume by
AQP1translocation inHEK293cell.Representative images showingx-y sur-
face area (SA) estimationof cell volume. Thebinary imageand surface area are
calculated from the z-stack plane at the maximum area. All measurements
were taken at 48 h post-transfection. A, HEK293 cells transfected with wild-
type AQP0-GFP. B, HEK293 cells transfected with wild-type AQP1-GFP. C,
HEK293 cells transfected with the T157A/T239A translocation-deficient
mutant of AQP1-GFP. Control medium and hypotonic medium are DMEM
with osmolalities of 322–374 mosM/kg H2O and 107–125 mosM/kg H2O
(dilutedwithwater), respectively. Distribution profiles along the line scans (in
yellow on the image) are displayed graphically by each image indicating AQP
distribution in control and hypotonic medium (a.u. is arbitrary units). All
images and analyses shown are a single representation contributing to the
mean value quoted in the text and in Table 1.
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residues of AQP1, individually, to alanine to remove the
putative phosphorylation site, and to aspartate to mimic the
charge induced by phosphorylation of threonine. This cre-
ated the AQP1-GFP mutants, T157A, T239A, T157D, and
T239D. Surprisingly, all four single mutants translocated to
the plasma membrane in hypotonic medium: the RMEs in
control medium were 22  3%, 21  5%, 24  3%, and 18 
5%, respectively, and were 75  2%, 81  9%, 73  6%, and
69  9% in hypotonic medium, respectively (Table 1). This
indicated that mutation of each putative phosphorylation
site affected neither AQP1 translocation nor its constitutive
surface localization.
In contrast, double mutation of both putative PKC phos-
phorylation sites to alanine, creating the mutant T157A/
T239A, completely ablated hypotonicity-induced transloca-
tion of AQP1-GFP: the RME in control medium was 21 5%
and in hypotonic medium was 21  2% (Table 1) even after
15 min of exposure. Double mutation of both putative PKC
phosphorylation sites to aspartate created the phosphomi-
metic mutant T157D/T239D. As expected, T157D/T239D
translocated to the plasma membrane following hypotonic
exposure (RME in control medium was 23  4% rising to
75 7% in hypotonic medium; Table 1). We concluded that
although the double aspartate mutant, T157D/T239D, was
not constitutively expressed at the cell surface, it is primed
for rapid translocation to the membrane following hypo-
tonic exposure.
AQP1 Translocation Regulates Changes in Cell Volume—
Changes in cell volume were estimated for cells transfected
with mutant AQP1 constructs. After a 30-s hypotonic expo-
sure, HEK293 cells transfected with the translocation-deficient
mutant T157A/T239A had an increase of 7  3% compared
with cells in DMEM (p  0.01; Fig. 2C). Cell volume was not
significantly different from wild-type (p  0.05) for all four
single mutants (T157A, T239A, T157D, and T239D) or the
T157D/T239D mutant. The difference in hypotonicity-in-
duced volume change between cells transfected with wild-type
AQP1-GFP (28  4%; Fig. 2B) and those transfected with the
translocation-deficient mutant (T157A/T239A) supports an
interpretation that AQP1 translocation to the plasma mem-
brane regulates changes in cell volume in response to hypotonic
conditions.
Phosphorylation Is Not Sufficient for Hypotonicity-induced
AQP1 Translocation—Incubation of cells expressing AQP1-
GFP with either the specific PKC inhibitor Myr-PKC 19–27
(19) or hypericin PKC inhibitor, inhibited hypotonicity-in-
duced subcellular localization of wild-type AQP1-GFP
(Table 1).We reasoned that if the T157D/T239Dmutant was
a mimic of a doubly phosphorylated state and hence was
primed for localization, these compounds should not inhibit
its translocation; indeed, no inhibition of hypotonicity-in-
duced translocation was observed (Table 1). The RME for
T157D/T239D in the presence of Myr-PKC 19–27 was 24
6% in control medium rising to 78  8% in hypotonic
medium. In the presence of hypericin the RME values of
T157D/T239Dwere 23 5% in control medium and 72 6%
in hypotonic medium. Importantly, the PKC activators,
PMA and 1-oleoyl-2-acetyl-sn-glycerol, did not stimulate
wild-type AQP1 translocation in control medium (following
incubation with PMA or 1-oleoyl-2-acetyl-sn-glycerol, RME
TABLE 1
Relative membrane expression and calcium responses of HEK293 cells expressing AQP1 or AQP1mutants
Experiments were performed in HEK293 cells expressing the proteins indicated and cultured in the specified medium. RME values are the mean S.E. of at least five line
scan analyses performed in triplicate on a minimum of three independent experiments. The intracellular calcium ([Ca2]i) responses are the mean S.E. of 100 individual
cell trace analyses of a minimum of three independent experiments. CaM indicates calmodulin, and OAG indicates 1-oleoyl-2-acetyl-sn-glycerol.
Construct/initial medium
RME initial
medium
RME following
hypotonic stimulus
Hypotonicity-induced
translocation of AQP
Hypotonicity-induced [Ca2]i
response (% of basal [Ca2]i)
Wild-type AQP1-GFP
Control medium 19 3% 73 5% Y 40 7%
CPA 18 4% 71 9% Y 43 12%
Extracellular calcium-free medium 21 4% 24 4% N 0 1%
Extracellular calcium-free medium CPA 23 3% 25 5% N 1 1%
Myr-PKC 19–27 inhibitor 21 2% 24 3% N 33 6%
Hypericin PKC inhibitor 22 4% 23 3% N
W7 CAM inhibitor 25 4% 28 6% N 38 7%
SKF96365 TRPC1 antagonist 26 5% 25 6% N
PMA PKC activator 20 2% 75 4% Y
OAG PKC activator 22 5% 71 7% Y
Caffeine 26 4% 72 6% y
T157A AQP1-GFP
Control medium 22 3% 75 2% Y 34 5%
T239A AQP1-GFP
Control medium 21 5% 81 9% Y 32 6%
T157D AQP1-GFP
Control medium 24 3% 73 6% Y 35 4%
T239D AQP1-GFP
Control medium 18 5% 69 9% Y 37 6%
T157A/T239A AQP1-GFP
Control medium 21 5% 21 2% N 46 10%
T157D/T239D AQP1-GFP
Control medium 23 4% 75 7% Y 40 7%
Myr-PKC 19–27 inhibitor 24 6% 78 8% Y
Hypericin PKC inhibitor 23 5% 72 6% Y
W7 calmodulin antagonist 28 5% 22 4% N
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remained at 20  2% and 22  5%, respectively, in control
medium and increased to 75 4% and 71 7%, respectively,
in hypotonic medium), indicating that an additional step is
required in the translocation mechanism.
Hypotonic Stimulus Required for AQP1 Translocation
Induces Increase in Intracellular Calcium—Following exposure
to hypotonic conditions, the swelling response of many mam-
malian cells has been shown to be calcium-dependent (21, 22).
To investigate a possible role for calcium in AQP1 transloca-
tion, we conducted real-time, intracellular calcium [Ca2]i,
imaging experiments using the fluorescent indicator Fluo-4
AM. Hypotonic stimulus (107–125 mosM/kg) induced a rapid
[Ca2]i increase (40 7% above basal levels; Fig. 3). We noted
that the osmolality of the hypotonic stimulus that resulted in
[Ca2]i elevations (Fig. 3) corresponded precisely with that
required forwild-typeAQP1 translocation and that both events
occurred within the same timeframe (10–30 s) (19).
Extracellular Calcium Influx Is Necessary for Hypotonici-
ty-induced AQP1 Translocation—To determine a role for
hypotonicity-induced [Ca2]i elevations in the rapid regula-
tion of AQP1 translocation, cells were incubated with 10 M
CPA for 30 min to inhibit intracellular calcium release from
internal stores and then exposed to hypotonic conditions.
An RME of 18 4% in isotonic control medium and 71 9%
in hypotonic medium after 30 s indicated that depletion of
intracellular calcium stores had little effect on AQP1 trans-
location (Fig. 4A and Table 1). In contrast, on removing
extracellular calcium prior to hypotonic exposure, we
observed only a transient translocation of AQP1-GFP in cal-
cium-free medium followed by a return to basal RME levels
(24  4% within 120 s) despite continued incubation in
hypotonic medium (Fig. 4B and Table 1). This is consistent
with calcium release from intracellular stores being
sufficient to induce transient translocation, but extracellular
calcium entry being necessary for sustained membrane
expression of AQP1. Indeed, similar results were obtained
for cells in calcium-free medium in the presence of 10 M
CPA (RME was 23  3% in control medium and 25  5% in
hypotonic medium; Fig. 4C and Table 1). For the mutant
constructs, a [Ca2]i, similar to that for wild-type AQP1-
GFP, of 34 5%, 32 6%, 35 4%, and 37 6% above basal
([Ca2]i) was measured for T157A, T239A, T157D, and
T239D, respectively (Table 1). A [Ca2]i increase similar to
that for wild-type AQP1-GFP was recorded for both double
mutants (Table 1). In support of these observations, addition
of caffeine alone, which has been shown to increase intracel-
lular calcium concentration in HEK cells (26), did not stim-
ulate sustained AQP1 membrane translocation in control
medium (RME remained at 26  4% in control medium and
increased to 72  6% in hypotonic medium). These results,
together with the reversal of calcium elevation and AQP1
translocation upon cessation of hypotonic stimulus, illus-
trate the dynamic effects that fluctuating calcium levels have
on AQP translocation.
Inhibition ofMechanosensitive TRPChannels Prevents Hypo-
tonicity-induced AQP1 Translocation—Calcium-permeable
TRP channels are involved in the response of mammalian cells
to changes in extracellular osmolality (38). The stretch-acti-
vated TRP channel, TRPC1 (39, 40), is known to be present in
HEK293 cells (41) and may be activated by the entry of water
through the AQP1 channels that are already present in the
membrane at a basal RME of 20  3% (Table 1) (19). Table 1
shows that in the presence of the specific TRPC1 antagonist,
SKF96365, hypotonicity-induced AQP1 translocation was
ablated (RME was 26 5% in control medium and 25 6% in
hypotonic medium).
Hypotonicity-induced AQP1 Translocation Is Mediated by
Calmodulin—Incubation of cells expressing wild-type AQP1-
GFP with 100 M W7 calmodulin antagonist for 30 min inhib-
ited hypotonicity-induced AQP1 translocation: RME values
were 25  4% in control medium and 28  6% in hypotonic
medium (Table 1). Furthermore, hypotonicity-induced subcel-
lular localization of the T157D/T239Dmutant was inhibited by
preincubation of cells expressing this mutant with 100 M W7
for 30 min (RME values for were 28  5% in control medium
and 22  4% in hypotonic medium; Table 1). This suggested
that, together with the requirement for specific PKC-depen-
dent phosphorylation and calcium influx through TRP chan-
FIGURE 3. Hypotonicity-induced intracellular Ca2 elevations and AQP1
translocation inHEK293cells.A, subcellular localizationofAQP1-GFP fusion
proteins in HEK293 cells before and after hypotonic stimulus. The same living
cells are shown in controlmedium (left panel) and in hypotonicmedium (right
panel). All measurements were taken at 48 h post-transfection. Fluorescence
amplitudes along the line scans (in yellow on the image) are displayed graph-
ically below each image indicating translocation of AQP1-GFP in response to
hypotonic stimulus (a.u. is arbitrary units). RME is calculated from at least five
line scan analyses performed in triplicate on a minimum of three indepen-
dent experiments. B, individual traces of calcium fluorescence versus time
(lower left panel) for 10 randomly selected cells from the images in the top
panels (scale in arbitrary units); i, ii, iii, and iv correspond to time points in the
traces). The mean normalized trace for 10 cells is shown (lower right panel).
The red bar indicates the timeof hypotonic exposure. All images and analyses
shown are a single representation contributing to the mean value quoted in
the text and in Table 1.
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nels, calmodulin is a further critical component of the AQP
translocation mechanism.
DISCUSSION
There are 13 known members of the AQP family in humans
(numbered AQP0 to AQP12), and they are found in different
tissues throughout the body; wherever there is water (42).
Impaired water homeostasis is associated with a wide range of
conditions such as diabetes, high blood pressure, and brain
swelling after stroke or head injury. These can become espe-
cially problematic as we age because the water content of our
body declines from 60–65% of body mass in middle age to 50%
by the age of 80 (43). Understanding the mechanisms of AQP
regulation will therefore open up new avenues for therapeutic
discovery.
Although recent advances have described AQP structure (5)
and have established the mechanism of water selectivity
through the AQP pore (3, 4), progress in understanding AQP
regulation in mammalian cells has been limited to the role of
AQP gene expression (9, 10) or AQP translocation via indirect
G protein-coupled receptor networks (44) in the medium to
long term (10). The latter has been comprehensively studied for
AQP2: endocrine activation of vasopressin V2 receptor is
required for membrane localization of constitutive, intracellu-
lar AQP2 on a 15–60 min time scale (13, 14, 45). In this study,
FIGURE 4. Hypotonicity-induced intracellular Ca2 elevations and AQP1 translocation in HEK293 cells cultured in calcium-free medium and/or with
depleted intracellular calcium stores. The subcellular localization of AQP1-GFP fusion proteins in HEK293 cells before and after hypotonic stimulus are
shown (A–C; left panels), where the same cells are in control medium (left panels) and hypotonic medium (right panels). All measurements were taken at 48 h
post-transfection. Fluorescence amplitudes along the line scans (in yellow on the image) are displayed graphically below each image, indicating subcellular
localization of AQP1-GFP (a.u. is arbitrary units). A shows wild-type-like hypotonicity-induced AQP1-GFP translocation in the presence of 10 M CPA. B shows
no hypotonicity-induced AQP1-GFP translocation in Ca2-freemedium. C shows no hypotonicity-induced AQP1-GFP translocation in Ca2-freemediumwith
10MCPA. The corresponding intracellular Ca2 responses of the cells are shown (upper right panels) withmean normalized traces of fluorescence versus time
shown below for 10 random cells from the images in the top panels (scale in arbitrary units); i, ii, iii, and iv correspond to time points in the traces. The mean
normalized trace for 10 cells is shown to the right. The red bar indicates the time of hypotonic exposure. All images and analyses shown are a single
representation contributing to the mean value quoted in the text and in Table 1.
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we describe a physiologically relevant (Fig. 1) and direct mech-
anism for the regulation of functional AQP1 translocation (Fig.
2) on a timescale of seconds (Fig. 5). This mechanism incorpo-
rates our previous observation that AQP1 translocation is
mediated by microtubules (19), which also have a role in AQP2
translocation (46).
Role for Calcium in Hypotonicity-induced AQP Trans-
location—The regulation of cell permeability via the action of
AQP channels is central to the control of cell water transport
and cell volume. Cells exposed to hypotonic stimuli often
exhibit calcium elevations (47), although little is known about
the role of this signal. The TRP calcium channel family can be
activated by extracellular hypotonicity (48, 49), andmembers of
this family have been shown to be involved in a hypotonicity-
induced reduction of AQP5 abundance over a period of hours
(50). However, to our knowledge, there is no previous indica-
tion that hypotonicity-induced calcium elevations directly
induce a rapid translocation of AQPs. The findings in this study
show that a cytosolic elevation of calcium following hypotonic
stimulus evokes, and is necessary for, the translocation ofAQP1
to the plasma membrane and that the inhibition of the TRP
channel endogenous to HEK293 cells (TRPC1) prevents the
hypotonicity-mediated subcellular localization of AQP1 to the
plasma membrane. Furthermore, sustained translocation was
induced in conditions where intracellular calcium stores were
depleted, but only transient translocation, with no maintained
plasma membrane localization, was induced in the absence of
extracellular calcium, indicating that a calcium signal derived
from extracellular or intracellular sources is sufficient. How-
ever, the absence of maintained plasmamembrane localization
with no external calcium, which would also lead to intracellular
store depletion, shows that a sustained calcium signal is neces-
sary for continued AQP1 plasma membrane localization. This
is supported by the observations that a return to control
medium and a reduction in calcium signal coincides with inter-
nalization of AQP1. Interestingly, as the sarco/endoplasmic
reticulum Ca2-ATPase inhibitor, CPA, had no effect on sus-
tained AQP1 localization, there may be no requirement for
extracellular calcium to first pass through the intracellular
stores. This may reflect that under normal conditions, the
influx of extracellular calcium is the key requirement.
Phosphorylation-dependent Mechanism for Rapid, Direct
Hypotonicity-induced AQP Translocation—The phosphoryla-
tion of AQPs is well established and several kinases are impli-
cated in observed increases in water permeability, including
protein kinases A and C, casein kinase II, and calcium/calmod-
ulin kinase (9).We show that in addition to the requirement for
calcium, hypotonicity-induced AQP1 translocation is both cal-
modulin- and PKC-dependent. The mechanism for the PKC-
dependent nature of this movement requires the synergistic
qualities of both known PKC phosphorylation sites of AQP1
(Thr-157 and Thr-239) (37). Neither residue, individually
substituted with alanine or aspartate, caused any obvious phe-
notype under our experimental conditions. However a double
alanine substitution (T157A/T239A) blocked all hypotonicity-
mediatedmovement of AQP1. The fact that the T157D/T239D
mutation did not result in constitutive plasmamembrane local-
ization is further consistent with our proposed mechanism in
which hypotonicity-induced calcium elevations are sustained
via extracellular-calcium influx and is mediated by calmodulin
(Table 1): the calmodulin antagonist, W7, inhibited hypotonic-
ity-induced AQP1 membrane localization but not hypotonici-
ty-induced calcium elevations. It would appear that theT157D/
T239D double mutation does not affect the calcium/
calmodulin mechanism but rather mimics the charges induced
by phosphorylation of Thr-157 and Thr-239, allowing translo-
cation to occur. The calmodulin antagonistW7 inhibited hypo-
tonicity-induced translocation of T157D/T239D but neither
PKC inhibitor had any effect on hypotonicity-induced translo-
cation of this construct. This T157D/T239D phosphomimetic
AQPmutant is primed for translocation and therefore does not
require PKC for membrane localization following hypotonici-
ty-induced influx of extracellular calcium and activation of a
calmodulin-dependent mechanism.
Implications—The speed of hypotonicity-induced AQP
translocation suggests that constitutively expressed AQPs
could participate in initial cell swelling. In many cells, this is
often followed by a regulatory volume decrease, achieved by the
efflux of ions by ion transporters and also organic osmolytes via
volume-regulated anion channels. Our findings show that
AQP1 translocation is also PKC- and calmodulin-dependent
similar to the translocation of volume-regulated anion channels
(51). It has also been suggested that hypotonicity may affect the
translocation of sodium channels in cultured renal cell lines
(52). Ion channel translocation in plant cells is known to be
regulated by hydrostatic pressure (53, 54) and hypotonicity
(55), whereas in animal cells, calcium-dependent exocytosis is a
majormechanism for the release of neurotransmitters and hor-
mones from neurones and endocrine cells (56).
In astrocytes, AQP1 is known to be involved in cell volume
regulation and cerebral edema (57, 58). In the kidney, AQP1
knock-out mice suffer from polyuria (59, 60). AQP1 (unlike
AQP2 in the collecting duct) is extensively found in the renal
proximal tubule and thin descending limb of Henle, the two
FIGURE 5. A model for the direct regulation of rapid cellular water flow.
Influx of water by osmosis and/or through constitutively expressed AQP
channels causes cell swelling and induces extracellular calciumentry through
TRP channels, thereby triggering AQP1 translocation. This translocation
along microtubules is dependent on calmodulin (CaM) activation and AQP1
phosphorylation by protein kinase C. Water subsequently enters or exits the
cell to maintain cellular homeostasis.
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regions responsible for reabsorbing 80% of the fluid from the
glomerular filtrate (61). It may be that the quickest response of
AQP1-expressing astrocytes and kidney cells to an increase in
cellular water levels is a hypotonicity-mediated increase in
available AQP1 at the appropriate membrane surface, as sug-
gested by studies of the long term expression of AQP1 (62). The
mechanisms underpinningAQP1 regulation therefore have the
potential to be manipulated for therapeutic benefit.
In conclusion, we have shown that rapid AQP1 translocation
involves calcium signaling indicating that this mechanism
mediates control of cellular water permeability in response to
physiological stimuli. As hypotonicity-induced translocation of
AQP1 involves ubiquitous and pluripotent calcium, the data
described here may serve as a universal prototype for rapid and
direct regulation of this important protein family.
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